Jobs
View more job listings or post a job
Quintara Discovery Research Scientist (Bioanalysis)
Quintara Discovery Research Scientist (Bioanalysis)
Chinook Therapeutics, Inc Sr. Scientist, In Vivo Pharmacology (Team Lead)
AbVision Senior/Principle Scientist (Immunology/Cell Biology)
Genentech, Inc. Associate Scientist, Biomarker Mass Spectrometry Laboratory  
Genentech, Inc. Senior Scientific Researcher for Biomarker Mass Spectrometry Laboratory
Genentech Inc. Contractor Scientist–Drug Metabolism
Genentech, Inc. Associate Scientist / Scientist, Biotransformation and ADME of New Modality  
Genentech, Inc. Scientist / Sr. Scientist, Drug Metabolism and Pharmacokinetics  
Pliant Therapeutics, Inc. Senior Research Associate, DMPK
Post a job

Seminar luncheon

Generating Efficacious Enzyme Therapeutics based on Knowledge Learned From Biocatalytic Pharmaceutical Manufacture


Speakers: Gjalt Huisman, SVP, Strategic Development (Codexis)
Organizers:
Date: 2019-07-26
Time: 11:30-13:30 Pacific Time
Registration fee: (USD): Food: $0.
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Almac
Vendor show vendors registered to date: (5)BUCHI Corporation; Cambrex; CoreRx; MicroConstants; PHC former Panasonic Healthcare
Registration: http://www.PBSS.org
Registration deadline:2019-07-25  (it will close sooner if the seating cap is reached)

About the Topic

Over the past 17 years, Codexis has applied its CodeEvolver® protein engineering platform to enable the efficient manufacture of small molecule pharmaceuticals at commercial scale. Recently, learnings from such programs inspired the development of therapeutic enzymes that are stable for function in the upper intestines, or that have been improved for systemic delivery via extension of  serum and lysosomal half-life, and reduced (predicted) immunogenicity. This presentation will highlight technical developments in both areas and provide a perspective on future implementation of this technology in the pharmaceutical industry.


About the Speakers

Dr. Gjalt Huisman is SVP Strategic Development at Codexis Inc. In this role he focuses on applying the companies’ technology to a broad range of application, including the generation of new therapeutic proteins. He received his PhD fromt he University of Groningen, the Netherlands, and was a post-doctoral fellow at Harvard Medical School. He co-authored 45 scientific papers and is a co-inventor on more than 50 patents.


2020-06-23, [Postponed due to COVID-19] Advances in Immuno-Oncology (A Joint Symposium by PBSS and BioScience Forum)
2020-09-17, Regulated Large Molecule Bioanalysis: Fundamentals, the New FDA Guidance and Beyond
2020-10-19, [New Date] Preclinical and Clinical Development of Cell-based Immunotherapies: Translational PKPD, Safety, Biomarker, CMC, Clinical Pharmacology & Clinical Trials
2021-07-29, Development of Inhalation Therapeutics (a joint symposium by AAPS-BADGE / PBSS / Genentech)
┬ęPharmaceutical & BioScience Society, International; Last Modified: 6/3/2020; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
Hypha Discovery Ltd. Experts in scalable synthesis & purification of drug metabolites, including CYP, AOX, FMO metabolites as well as O-, N-, acyl glucuronides & sulfates.
Submit a Text Ad